BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
2.770
+0.030 (1.09%)
At close: Jun 12, 2026, 4:00 PM EDT
2.780
+0.010 (0.36%)
After-hours: Jun 12, 2026, 6:52 PM EDT
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of $23.92 million as of June 12, 2026. Its market cap has increased by 106.18% in one year.
Market Cap
23.92M
Enterprise Value
1.12M
1-Year Change
106.18%
Ranking
Category
Stock Price
$2.77
Market Cap Chart
Since February 24, 2021, BriaCell Therapeutics's market cap has decreased from $26.00M to $23.92M, a decrease of -8.01%. That is a compound annual growth rate of -1.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 25.10M | 87.31% |
| Dec 31, 2025 | 13.40M | -46.40% |
| Dec 31, 2024 | 25.00M | -73.26% |
| Dec 29, 2023 | 93.50M | 37.91% |
| Dec 30, 2022 | 67.80M | -46.74% |
| Dec 31, 2021 | 127.30M | 389.62% |
| Feb 24, 2021 | 26.00M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dyadic International | 25.50M |
| Quantum BioPharma | 25.27M |
| Lite Strategy | 25.22M |
| Tvardi Therapeutics | 24.77M |
| Pluri | 24.49M |
| Longeveron | 24.38M |
| Neuphoria Therapeutics | 23.62M |
| Marker Therapeutics | 23.01M |